Ralph Brandenberger
Directeur Technique/Scientifique/R&D chez NKARTA, INC.
Fortune : 543 010 $ au 31/05/2024
Provenance du réseau au premier degré de Ralph Brandenberger
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 | |
17
| Public Company | Biotechnology | 17 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ralph Brandenberger via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer General Counsel Director of Finance/CFO | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Rotation Medical, Inc.
 Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | Medical Specialties | Director/Board Member Director/Board Member | |
| SENTI BIOSCIENCES, INC. | Biotechnology | President Director of Finance/CFO | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Applied Immune Sciences, Inc.
 Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Medical Specialties | Chief Tech/Sci/R&D Officer Founder | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| PERSONALIS, INC. | Medical/Nursing Services | Director/Board Member Chairman | |
| Geron Bio-Med Ltd. | Chairman Director/Board Member | ||
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| RELAY THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Masters Business Admin | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Doctorate Degree Corporate Officer/Principal | |
| California Institute for Regenerative Medicine | General Government | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 50 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Health Services | 2 |
| Government | 2 |
Opérationnelle
| Director/Board Member | 291 |
| Independent Dir/Board Member | 98 |
| Corporate Officer/Principal | 98 |
| Chairman | 55 |
| Chief Executive Officer | 53 |
Relations les plus connectées
| Insiders | |
|---|---|
| John P. Walker | 39 |
| Ali Behbahani | 35 |
| Ho Young Huh | 32 |
| Robert Spiegel | 30 |
| Alan Colowick | 30 |
| Karin Eastham | 29 |
| Charles Homcy | 28 |
| Fouad Azzam | 25 |
| Paul Hastings | 25 |
| Patrick Zenner | 24 |
| V. Lawlis | 21 |
| Alexander E. Barkas | 19 |
| Laura Shawver | 18 |
| Michael Dybbs | 17 |
| Leone Patterson | 14 |
- Bourse
- Insiders
- Ralph Brandenberger
- Connexions Sociétés
